References
- Shegokar R, Singh KK. Conversion of stavudine lipid nanoparticles into dry powder. Int J Pharm Bio Sci 2011;2:P443–P457
- Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm 1997;157:171–179
- del Pozo-Rodríguez A, Solinís MA, Gascón AR, Pedraz JL. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm 2009;71:181–189
- Cavalli R, Caputo O, Carlotti ME, et al. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm 1997;148:47–54
- Subedi RK, Kang KW, Choi H-K. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 2009;37:508–513
- Ramasamy T, Khandasami US, Ruttala H, Shanmugam S. Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent. Macromol Res 2012;20:682–692
- Kamiya S, Kurita T, Miyagishima A, et al. Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying. Eur J Pharm Biopharm 2010;74:461–466
- Lopes R, Eleuterio CV, Gonçalves LMD, et al. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur J Pharml Sci 2012;45:442–450
- Sandri G, Bonferoni MC, Gökçe EH, et al. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems. J Microencapsul 2010;27:735–746
- Sundaramurthi P, Suryanarayanan R. Influence of crystallizing and non-crystallizing cosolutes on trehalose crystallization during freeze-drying. Pharm Res 2010;27:2384–2393
- Sundaramurthi P, Patapoff T, Suryanarayanan R. Crystallization of trehalose in frozen solutions and its phase behavior during drying. Pharm Res 2010;27:2374–2383
- Vighi E, Ruozi B, Montanari M, et al. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm 2007;67:320–328
- Huang X, Chen Y-J, Peng D-y, et al. Solid lipid nanoparticles as delivery systems for Gambogenic acid. Colloids Surf B Biointerfaces 2013;102:391–397
- Zimmermann E, Muller RH, Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 2000;196:211–213
- Date PV, Samad A, Devarajan PV. Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying. AAPS PharmSciTech 2010;11:304–313
- Cui Z, Hsu C-H, Mumper RJ. Physical characterization and macrophage cell uptake of Mannan-coated nanoparticles. Drug Dev Ind Pharm 2003;29:689–700
- Doktorovova S, Shegokar R, Rakovsky E, et al. Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies. Int J Pharm 2011;420:341–349
- Zhang L, Liu L, Qian Y, Chen Y. The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). Eur J Pharm Biopharm 2008;69:750–759
- Pathak P, Nagarsenker M. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech 2009;10:985–992
- Souza LG, Silva EJ, Martins ALL, et al. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur J Pharm Biopharm 2011;79:189–196
- Siddiqui A, Gupta V, Liu Y-Y, Nazzal S. Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES). Int J Pharm 2012;431:222–229
- Choi SH, Jin S-E, Lee M-K, et al. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Eur J Pharm Biopharm 2008;68:545–554